Switching among antiretroviral agents when one is found to cause hyperlipidemia should be done cautiously because of the risk for viral rebound and disease progression. NCEP guidelines recommend ...

In addition, the excess burden and clustering of other risk factors for CVD in racial/ethnic minorities will affect intensity of therapy and target goals for management of hyperlipidemia.